Rain Oncology Inc
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss (NCT06090318) | Rain Oncology Inc | 2023-05-19 |
| A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects (NCT05758818) | Rain Oncology Inc | 2023-04-17 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (NCT04979442) | Rain Oncology Inc | 2021-07-14 |
| Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (NCT03805841) | Rain Oncology Inc | 2019-03-13 |
Track Rain Oncology Inc automatically
Every clearance here is in the API, with alerts when new ones post.